Lilly’s orforglipron outperforms oral semaglutide in Phase 3 diabetes trial
Results from the ACHIEVE programme show A1C reduction and weight loss outcomes for orforglipron across three Phase 3 trials
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Type 2 diabetes treatment
Zydus Lifesciences to launch Semaglutide Injection in India after patent expiry
Company plans rollout under SEMAGLYN, MASHEMA and ALTERME brands with adjustable single-pen device
Biomea Fusion reports blood sugar control with icovamenib in type 2 diabetes study
Mid-stage trial results show sustained blood sugar reduction and potential benefit for patients unresponsive to GLP-1 therapies
Eli Lilly shares results from QWINT trials on once-weekly insulin efsitora for type 2 diabetes
Efsitora met primary endpoints across three Phase 3 trials, showing comparable glucose control to daily basal insulin therapies
Abbott and MSD Pharmaceuticals partner to distribute oral anti-diabetic medicines in India
Through this agreement, Abbott will distribute MSD’s Januvia, Janumet, and Janumet XR across India to support diabetes management…